Joachim Eeckhout, Author at Labiotech.eu

About

Founder & Managing Director at Labiotech.eu. While I was studying biotechnology in Paris, I got frustrated by the lack of digital media available for the industry and decided to fix it! I launched Labiotech.eu in 2014 and grew it to the largest community for biotech professionals in Europe! Other than biotech news, I’m also a heavy reader of Sci-Fi and Fantasy.

Articles by Joachim Eeckhout

News and Trends 2 Oct 2015

BBSRC: Profile of a UK Biosciences Research Council

A brief profile of The Biotechnology and Biological Sciences Research Council (BBSRC). The BBSRC is the largest UK research council for non-medical biosciences, looking to dominate market in promoting public dialogue on bioscience and funding curiosity-led research, through a direct investment in bioscience research in UK universities and institutes. In particular BBSRC is aiming at promoting […]

October 2, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 Sep 2015

Bio-mining the Diversity of Deserts: A Biotech industry Goldmine

Deserts can be either hot or cold according to their geographical location, leading to the evolution of extremophilic organisms which are adapted to withstand such hostile living conditions. Here, we explore some of the potential industrial biotech applications of desert microbes, from bioremediation of pollutants such as PCP, to the investigation of novel anti-cancer compounds. […]

September 28, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 27 Sep 2015

What Happened this Week? Human Embryos Back on the Bench, Stem Cells in your Heart and New Antibiotics

Monday: Nabriva Therapeutics launched its $100M IPO on the NASDAQ to develop new antibiotics Tuesday: the Francis Crick Institute announced its application to conduct new research on human embryos Wednesday: Israeli NovoCure announced an IPO on NASDAQ with a target of €170M Thursday: Belgian TiGenix NV released the phase I results of their cardiac stem-cell therapy […]

September 27, 2015 - 1 minutemin - By Joachim Eeckhout

News and Trends 24 Sep 2015

Crowdsourcing for Innovation: BioMed X has just the right Recipe

Ever heard of BioMed X? If you are curious about innovation crowdsourcing, you should definitely check them out. BioMed X is one of the first companies to use crowdsourcing to discover new innovation in the life sciences, through which a biotech team has been assembled and financed to develop a new treatment for COPD. Chronic obstructive pulmonary […]

September 24, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 21 Sep 2015

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

New GMO rice variety has an increased starch content coupled with low greenhouse gas emissions. By making these GM rices more eco-friendly as well as improving their nutritional value, this research could potentially sway the public and political stigma against this life-altering technology, in the mission to save millions. As we all know, grains such as Golden […]

September 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 18 Sep 2015

Discover the Worlds first Bioactive Toilet Paper from Italy

Papernet biotech (part of the Italian Sofidel Group) launched their biological toilet paper back in 2007 as an answer to our hygiene based ecological crisis. With over 7Bn rolls produced per year in the US alone, Papernet is an award-winning subsidiary of the hygiene giant’s portfolio. The invention of using paper for hygiene purposes was […]

September 18, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 14 Sep 2015

High-Throughput screening of drug candidates made easier by FRETinFLOW

A multidisciplinary team from France has come up with a robust approach to detect molecular interactions in a reliable way using flow cytometry. This technology could lead to the discovery of new drugs via High-Throughput screening. Flow cytometry is a laser-based, biophysical technology employed by scientists all over the world to count and sort cells. It does this by […]

September 14, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 13 Sep 2015

What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!

Monday: A report said that the total value of crowdfunded Biotech projects from within the EU since 2010 is €23M. Tuesday: Researchers from University of Leeds unraveled the mechanism of cancer-targeting effects of Wasp venom. Wednesday: Kymab has been listed in the Sunday Times Tech Track ‘One’s to Watch’ 2015 just this month! Thursday: CureVac just announced the opening of its subsidiary […]

September 13, 2015 - 1 minutemin - By Joachim Eeckhout

News and Trends 12 Sep 2015

London’s Stock Market is on Fire: Two New Biotech Companies are Going Public

After the invasion of the London stock exchange by US-based companies PureTech (€147M raised) and Verseon (€92M raised) last June, it’s now the turn of two EU companies to go public in the British capital. Shield Therapeutics wants to grab a massive £110 million, while Faron Pharmaceuticals had not disclose its intention yet. Faron, based in Turku (Finland), […]

September 12, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 10 Sep 2015

CureVac, the mRNA Therapy Leader, is invading Moderna’s Homeland!

One more hit to Moderna Therapeutics struck by its German competitor CureVac! The Tübingen-based company just announced the opening of its subsidiary in Boston – hometown of Moderna – and a research collaboration with the U.S. non-profit International AIDS Vaccine Initiative (IAVI) to develop a mRNA-based HIV treatment. CureVac, today announced the official launch of its U.S. operations in […]

September 10, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 7 Sep 2015

A reliable technology to develop the next generation of GPCR targeted medicines

You must have heard of GPCRs, or more specifically G protein-coupled receptors. Doesn’t ring a bell? You know, it’s this large protein family of receptors that sense molecules outside the cell and trigger an inside signal. A technology called IP-One could give a large advantage to scientists working on GPCR-targeted drugs. We had the opportunity to […]

September 7, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 22 Aug 2015

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Welcome in our Top of the week list! This week is full of uncommon stories. Did you know that we can create the best coffee from Biotech techniques? The New York-based startup Afineur can do this! Even more crazy, what do you think of a DNA-made computer? Quite strange, right! Well, if you’re curious, read […]

August 22, 2015 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Joachim Eeckhout

About

Articles by Joachim Eeckhout

BBSRC: Profile of a UK Biosciences Research Council

Bio-mining the Diversity of Deserts: A Biotech industry Goldmine

What Happened this Week? Human Embryos Back on the Bench, Stem Cells in your Heart and New Antibiotics

Crowdsourcing for Innovation: BioMed X has just the right Recipe

How can we increase the nutritional value of GMO-rice whilst cutting greenhouse emissions?

Discover the Worlds first Bioactive Toilet Paper from Italy

High-Throughput screening of drug candidates made easier by FRETinFLOW

What happened this week? An award for Kymab, disappointment for Crowdfunding and some Wasps to save us!

London’s Stock Market is on Fire: Two New Biotech Companies are Going Public

CureVac, the mRNA Therapy Leader, is invading Moderna’s Homeland!

A reliable technology to develop the next generation of GPCR targeted medicines

What happened this week? Biotech revolutionizes Coffee, Paris N°1 Biocluster, a DNA-made Computer…

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Joachim Eeckhout

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!